United States· US:54473-304_7fbf2b51-9097-0a1f-e053-2991aa0a6aa1

CounterAct

A medicinal product containing diphenhydramine hydrochloride; acetaminophen, registered in United States by Melaleuca, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCounterActATC—REGISTER NO.US:54473-304_7fbf2b51…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN
Manufacturer
Melaleuca, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    5447330401
    1 BOTTLE in 1 BOX (54473-304-01) / 50 TABLET in 1 BOTTLE (54473-304-50)
  • ndc11
    54473-304-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diphenhydramine hydrochloride; acetaminophen in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diphenhydramine hydrochloride; acetaminophen products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Spain · Dolomidina
  • United Kingdom (Northern Ireland) · Panadol Night, Panadol Nightpain
  • Ireland · Dozol, Panadol Night
  • Malta · Dozol, Teedex
  • Poland · Apap Noc, Paracetamol + Difenhydramina Noc Hasco
  • Portugal · Algik Noite, Chrobion

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0a0cdd16-7a12-4367-841e-28fb11f1b856
GET /v1/drugs/0a0cdd16-7a12-4367-841e-28fb11f1b856?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "25; 500",
  "substance": "DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN",
  "productndc": "54473-304",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "part343",
  "marketing_category": "OTC MONOGRAPH NOT FINAL"
}

See everything about diphenhydramine hydrochloride; acetaminophen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.